| Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
|---|
| 04/13/2010 | CA2431976C Lithium complexes of n-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, their production and use |
| 04/08/2010 | US20100087496 Novel cinnamic amide derivatives useful as ion channel modulators |
| 04/07/2010 | EP2170345A1 Therapeutic substituted cyclopentanes for reducing intraocular pressure |
| 04/06/2010 | US7692024 Gas generant compositions |
| 04/06/2010 | US7691892 Tetrazole compounds and their use as metabotropic glutamate receptor antagonists |
| 04/06/2010 | US7691891 Diphenylurea derivatives and their use as chloride channel blockers |
| 04/06/2010 | US7691860 Neuropeptide Y receptor antagonists; such as 2-(trans-4-tert-butylsulfonylaminocyclohexyl)-5-(trifluoromethyl)benzimidazole; bulimia, obesity, diabetes |
| 04/06/2010 | CA2464846C Dibenzylamine compounds and pharmaceutical use thereof |
| 04/06/2010 | CA2416220C Preparation of phosphatase inhibitors |
| 04/01/2010 | US20100081826 7-pyrrolyl tetracycline compounds and methods of use thereof |
| 04/01/2010 | US20100081799 Chelating Agent |
| 03/31/2010 | EP2168576A2 New utilities of tricyclic compounds |
| 03/31/2010 | EP2167477A2 Improved process for preparing pure valsartan |
| 03/31/2010 | EP1620091B1 Inhibitors of glutaminyl cyclase |
| 03/31/2010 | CN101687803A Metal chelates having a perfluorinated peg group, method for the production thereof, and use thereof |
| 03/31/2010 | CN101684104A 5-iodotetrazoles |
| 03/25/2010 | WO2010011367A3 Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using |
| 03/25/2010 | WO2010003084A3 Phosphodiesterase 4 inhibitors |
| 03/25/2010 | US20100076188 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 03/25/2010 | US20100076028 Design and Synthesis of Novel Antimicrobials |
| 03/25/2010 | US20100076027 Indazole or 4,5,6,7-tetrahydro-indazole derivatives |
| 03/17/2010 | EP1817300B1 Potentiators of glutamate receptors |
| 03/16/2010 | US7678918 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents |
| 03/11/2010 | WO2010006755A3 Cyclic polyamines for binding phosphatidylserine |
| 03/11/2010 | WO2009148291A3 3- or 4-substituted piperidine compounds |
| 03/11/2010 | WO2009148290A3 3-substituted propanamine compounds |
| 03/11/2010 | US20100063299 Process for Preparing Irbesartan |
| 03/10/2010 | EP2160384A1 Process for the preparation of valsartan |
| 03/09/2010 | US7674887 3'-{N'-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid; thrombocytopenia and megakaryocytopoiesis treatment |
| 03/09/2010 | US7674886 Chelation compounds, radionuclides |
| 03/09/2010 | US7674797 2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
| 03/04/2010 | WO2010025197A1 Process for preparing certain cinnamide compounds |
| 03/04/2010 | WO2010022565A1 Tetrazole derivatives and light sensitive poly(dimethylsiloxane) for complex pattern formation |
| 03/04/2010 | US20100056797 Process for the Preparation of Irbesartan |
| 03/04/2010 | US20100056777 Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring |
| 03/04/2010 | US20100056776 Method of preparing macromolecular contrast agents and uses thereof |
| 03/04/2010 | US20100055043 Poly-Halo Metal X-ray Contrast Agents |
| 03/04/2010 | CA2733606A1 Process for preparing certain cinnamide compounds |
| 03/03/2010 | EP1389183B1 Sulfonamide derivatives |
| 03/03/2010 | CN101663284A Macrocyclic compounds as hcv ns3 protease inhibitors |
| 03/02/2010 | US7670991 Substituted benzoylcyclohexenones and their use as herbicidal agents |
| 02/25/2010 | WO2010022249A2 Macrocyclic compounds for inhibition of tumor necrosis factor alpha |
| 02/25/2010 | WO2010021351A1 Cycloalkylamine derivative |
| 02/25/2010 | US20100048911 Antioxidant inflammation modulators: novel derivatives of oleanolic acid |
| 02/25/2010 | US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 02/25/2010 | CA2733790A1 Macrocyclic compounds for inhibition of tumor necrosis factor alpha |
| 02/24/2010 | EP2155700A1 Beta-keto-amide derivatives useful as ion channel modulators |
| 02/24/2010 | CN100591674C Method for catalytic synthesis of 5-substituted tetrazole by tungstate |
| 02/23/2010 | US7667045 Gas generant and synthesis |
| 02/23/2010 | US7666866 Antithrombotic diamides |
| 02/23/2010 | US7666857 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3′-(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline |
| 02/23/2010 | CA2329930C Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 02/18/2010 | WO2008007391A3 An improved process for the preparation of valsartan |
| 02/18/2010 | US20100041904 Antioxidant inflammation modulators: c-17 homologated oleanolic acid derivatives |
| 02/18/2010 | DE102005011563B4 Verfahren zur Herstellung von Explosivstoffen A process for the production of explosives |
| 02/17/2010 | EP2152678A1 Process for preparing valsartan |
| 02/17/2010 | EP2152677A1 Acetamide derivatives as potassium channel modulators |
| 02/17/2010 | EP2152664A1 Dipeptide analogs as coagulation factor inhibitors |
| 02/17/2010 | CN101648918A Intermediate compound of candesartan cilexetil and synthesis method thereof |
| 02/16/2010 | US7662977 Such as 2-cationic amino-4-oxo-chromene derivatives; water solubility, pharmacokinetics; reduced side effects; anticancer agents |
| 02/16/2010 | US7662839 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders; e.g. {4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl}-acetic acid |
| 02/16/2010 | CA2442882C Sulphones which modulate the action of gamma-secretase |
| 02/11/2010 | WO2010016549A1 Tricyclic compound |
| 02/10/2010 | EP2151236A1 G-protein-conjugated receptor agonist |
| 02/10/2010 | EP2150532A1 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase |
| 02/09/2010 | US7659406 Process for preparing valsartan |
| 02/09/2010 | US7659400 Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging |
| 02/09/2010 | US7659393 Chemical intermediates of gadolinium complexes and cyclene ligand polyfunctinalized with carboxylate arms such as Dotarem, Prohance (gadoteridol) , andGadovist; one pot process of reacting ethyenediamine, glyoxal andbenzotriazole without using dibromo- or dichloroethane |
| 02/09/2010 | US7659276 1-{[1-(2,6-dimethylphenyl)-1H-tetrazol-5-yl]phenylmethyl}-4-(3-phenylallyl)piperazine; G-protein coupled receptor antagonist; antidepressant, anxiolitic agent, obesity |
| 02/09/2010 | CA2407112C Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents |
| 02/09/2010 | CA2201863C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors |
| 02/09/2010 | CA2192092C Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 02/04/2010 | WO2010012442A2 Insecticidal benzenedicarboxamide derivative |
| 02/04/2010 | US20100028936 Detection of cancer cells in vitro using sigma-2 receptor ligands as radiotracers |
| 02/03/2010 | EP2149567A1 Cyclic polyamines for binding phosphatidylserine |
| 02/02/2010 | US7655684 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease |
| 02/02/2010 | CA2541301C P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same |
| 01/28/2010 | WO2010009879A2 Methods for producing paricalcitol |
| 01/28/2010 | WO2010009508A1 Antiparasitic compounds |
| 01/28/2010 | WO2009124962A3 Sulfonamides |
| 01/27/2010 | EP2146971A1 Novel benzamidine derivatives useful as potassium channel modulators |
| 01/27/2010 | EP1438298B1 Piperazine derivatives with ccr1 receptor antagonist activity |
| 01/27/2010 | CN101633646A Salts of valsartan |
| 01/26/2010 | US7652147 Process for preparation of Irbesartan |
| 01/26/2010 | CA2310324C Method for preparing bromomethyl-biphenyl derivatives |
| 01/21/2010 | WO2010006755A2 A compound for imaging cell death |
| 01/21/2010 | US20100016597 Method for producing pulverized organic compound particle |
| 01/21/2010 | US20100016545 Process for the covalent coupling of two molecules by means of a diels-alder reaction with inverse electron requirement |
| 01/21/2010 | US20100016383 4-(3,3-dihalo-allyloxy)phenol derivatives having pesticidal properties |
| 01/21/2010 | CA2731053A1 A compound for imaging cell death |
| 01/20/2010 | EP1202961B1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 01/19/2010 | US7648971 Thrombopoietin mimetics |
| 01/14/2010 | US20100010061 Cb1 receptor modulators |
| 01/14/2010 | US20100008857 Novel hexatriene-beta-carbonyl compound |
| 01/13/2010 | EP1144388B1 Acyl derivatives which treat vla-4 related disorders |
| 01/12/2010 | US7645883 Comprising triazolium salt; eutectics; explosive TNT replacements |
| 01/12/2010 | US7645799 thromboembolic and/or inflammatory disorders; 4-Aminomethyl-cyclohexanecarboxylic acid (1-biphenyl-3-yl-2-phenyl-ethyl)-amide; selective inhibitors of serine protease enzymes of the coagulation cascade and/or contact activation system; improved pharmacological properties, plasma kallikrein activity |
| 01/12/2010 | CA2407463C N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 01/07/2010 | WO2010003084A2 Phosphodiesterase 4 inhibitors |
| 01/07/2010 | WO2009117421A3 Heterocyclic modulators of gpr119 for treatment of disease |